RAMACL
RNA guanine-N7 methyltransferase-activating subunit-like protein
Also known as: RMACL_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- A0A3B3IU46
- Gene
- RAMACL
- Canonical length
- 118 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for RAMACL in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
118 residues, UniProt reviewed canonical sequence.
>A0A3B3IU46|RAMACL
1 MTDTAEAVPN FEEMFASRFT ENDKEYQEYL KRPPESPPIV EEWNSRAGGN QRNRGNRLQD
61 NRQFRGRDNR WGWPSDNRSN QWHGRSWGNN YPQHRQEPYY PQQYGHYGYN QRPPYGYYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAMACL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 0.9 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0.9 nTPM
- skin: 0.8 nTPM
- breast: 0.6 nTPM
- lung: 0.6 nTPM
- skeletal muscle: 0.6 nTPM
- vagina: 0.6 nTPM
Single-cell type
- late spermatids: 0.6 nCPM
- foveolar cells: 0.4 nCPM
- enterocytes: 0.1 nCPM
- epididymal efferent duct absorptive cells: 0.1 nCPM
- pancreatic acinar cells: 0.1 nCPM
- adipocytes: 0 nCPM
Immune cell
- neutrophil: 1.6 nTPM
- eosinophil: 1.3 nTPM
- memory B-cell: 1 nTPM
- naive B-cell: 1 nTPM
- myeloid DC: 0.9 nTPM
- NK-cell: 0.9 nTPM
Brain region
- white matter: 9.6 nTPM
- medulla oblongata: 7.3 nTPM
- hypothalamus: 6.3 nTPM
- pons: 6.3 nTPM
- amygdala: 6.1 nTPM
- thalamus: 5.9 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAMACL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAMACL as an antibody target. Whether an autoantibody or antibody against RAMACL could matter depends on whether native RAMACL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAMACL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RAMACL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...